key: cord-0913285-l9vtsj3e authors: Dilucca, Maddalena; Forcelloni, Sergio; Pavlopoulou, Athanasia; Georgakilas, Alexandros G.; Giansanti, Andrea title: Codon usage and evolutionary rates of the 2019-nCoV genes date: 2020-03-29 journal: bioRxiv DOI: 10.1101/2020.03.25.006569 sha: f77c312d09d1a67173ad18b96b302821768589ad doc_id: 913285 cord_uid: l9vtsj3e Severe acute respiratory syndrome coronavirus 2 (2019-nCoV), which first broke out in Wuhan (China) in December of 2019, causes a severe acute respiratory illness with a mortality ranging from 3% to 6%. To better understand the evolution of the newly emerging 2019-nCoV, in this paper, we analyze the codon usage pattern of 2019-nCoV. For this purpose, we compare the codon usage of 2019-nCoV with that of other 30 viruses belonging to the subfamily of orthocoronavirinae. We found that 2019-nCoV shows a rich composition of AT nucleotides that strongly influences its codon usage, which appears to be not optimized to human host. Then, we study the evolutionary pressures influencing the codon usage and evolutionary rates of the sequences of five conserved genes that encode the corresponding proteins (viral replicase, spike, envelope, membrane and nucleocapsid) characteristic of coronaviruses. We found different patterns of both mutational bias and nature selection that affect the codon usage of these genes at different extents. Moreover, we show that the two integral membrane proteins proteins (matrix and envelope) tend to evolve slowly by accumulating nucleotide mutations on their genes. Conversely, genes encoding nucleocapsid (N), viral replicase and spike proteins are important targets for the development of vaccines and antiviral drugs, tend to evolve faster as compared to other ones. Taken together, our results suggest that the higher evolutionary rate observed for these two genes could represent a major barrier in the development of antiviral therapeutics 2019-nCoV. The name "coronavirus" is derived from the Greek κoρωνα, that mean crown. The first complete The aim of this study was to carry out a comprehensive analysis of codon usage and composition of 48 coronavirus and explore the possible leading evolutionary determinants of the biases found. [19]. For nCoV we note a different trend T>A>G>C, but in totally AT% is more used than GC% (See 54 Table 3 ). The GC content in 2019-nCoV is 0.373 ± 0.05. 55 2.2. All the sequenced 2019-nCoV genomes share a common codon usage 56 We downloaded the protein-coding sequences of 2019-nCoV from GIDAID database, by did not cluster according to geographic location, thus confirming the common origin of these genomes. 63 Therefore, we will consider a unique vector to represent 2019-nCoV in the following analyses. 65 We compared the codon usage of 2019-nCoV with that of the other coronavirus genomes. For 66 this purpose, we used the RSCU which is a biologically relevant metric of distance between the codon 67 usage in the protein-coding sequences of these genomes. In Fig. 1 , we report the heatmap of the RSCU Figure A3 ). In line with previous observations, we show that the mean CpG relative abundance in the coronavirus genomes is markedly suppressed [27] . Specifically, GGG, GGC, CCG (pyrimidine-CpG) 74 and ACG (purine-CpG) present a very low frequence of occurrence, probably due to the relative tRNA 75 abundance of the host. In fact, in human the abundance of tRNA in codons GGG, GGC, CCG and 76 ACG are respectavely: 0, 0, 4 and 7. 77 In 2019-nCoV, the most frequently used codons are CGU (arginine, 2.34 times) and GGU (glycine, 78 2.42), whereas the least used codons are GGG (glycine) and UCG (serine). We also note the most 79 frequently used codons for each amino acid, ended in either U or A. 2.4. The codon usage of 2019-nCoV is not optimized to the host. 81 To measure the codon usage bias in the coronavirus genomes, we used the effective number 82 of codons (ENC) value and the Competition Adaptation Index (CAI). In Table 2 and 3, we report 83 the ENC and CAI values for all the coronaviruses we considered in this work. To visually enhance 84 the differences among the codon usage of these coronaviruses we calculated Zscore of a single virus 85 in relation to the other members of the CoV subfamily. Interestingly, the ENC value associated to 86 2019-nCoV (51.9 ± 2.59) is lower than the average of all Coronaviruses, meaning that 2019-nCoV uses 87 a broader set of synonymous codons in its coding sequences. We also note that CAI of 2019-nCoV 88 (0.727 ± 0.054) is lower than the average one, underscoring that this coronavirus tend to use codons 89 that are not optimized to the host. We calculate similarity index (SiD) to measure the effect of codon is considered as a pure mutational parameter. In Figure 5 , we report the neutrality plots obtained for 133 genes M, N, S, E, RdRP, together with the best-fit lines and the slopes associated with them. The rationale to understand the results is that the wider is the deviation between the slope of the Overall, protein and DNA sequence divergences are linearly correlated, and these correlations 163 can be expressed through slopes and intercepts of the regression lines. Genes M and E show quite low slopes, indicating that these proteins tend to evolve slowly by 165 accumulating nucleotide mutations on their genes. Conversely, the steeper slopes for genes N, RdRP, 166 and S indicate that these genes tend to evolve faster compared to other ones. A plausible explanation 167 for this observation is that protein N due to its immunogenicity, has been frequently used to generate 168 specific antibodies against various animal coronavirus, including in SARS [24] . The viral replicase 169 polyprotein that is essential for the replication of viral RNA and, finally, the gene S encodes the protein 170 that is responsible for the "spikes" present on the surface of coronaviruses. Taken together, our results 171 suggest that the higher evolutionary rate observed for these proteins could represent a major obstacle 172 to in the development of a antiviral therapeutics against 2019-nCoV. ENC is an estimate of the frequency of different codons used in a coding sequence. In general, ENC ranges from 20 (when each aminoacid is coded by just one and the same codon) to 61 (when all synonymous codons are used on an equal footing). Given a sequence of interest, the computation of ENC starts from F α , a quantity defined for each family α of synonymous codons (one for each amino acid): where m α is the number of different codons in α (each one appearing n 1 α , n 2 α , ..., n m α times in the sequence) and n α = ∑ m α k=1 n k α . ENC then weights these quantities on a sequence: where N S is the number of families with one codon only and K m is the number of families with 235 degeneracy m (the set of 6 synonymous codons for Leu can be split into one family with degeneracy 2, 236 similar to that of Phe, and one family with degeneracy 4, similar to that, e.g., of Pro). 237 We have evaluated ENC by using the implementation in DAMBE 5.0 [31]. Codon adaptation index CAI [? ] is used to quantify the codon usage similarities between the virus and host coding sequences. The principle behind CAI is that codon usage in highly expressed genes can reveal the optimal (i.e., most efficient for translation) codons for each amino acid. Hence, CAI is calculated based on a reference set of highly expressed genes to assess, for each codon i, the relative synonymous codon usages (RSCU i ) and the relative codon adaptiveness (w i ): In the RSCU i , X i is the number of occurrences of codon i in the genome, and the sum in the denominator runs over the n i synonyms of i; RSCUs thus measure codon usage bias within a family of synonymous codons. w i is then defined as the usage frequency of codon i compared to that of the optimal codon for the same amino acid encoded by i-i.e., the one which is mostly used in a reference set of highly expressed genes. The CAI for a given gene g is calculated as the geometric mean of the usage frequencies of codons in that gene, normalized to the maximum CAI value possible for a gene with the same amino acid composition: where the product runs over the l g codons belonging to that gene (except the stop codon). This index values range from 0 to 1, where the score 1 represents the tendency of a gene to always To study the patterns of codon bias in the coronaviruses, we use Z-score values: where ENC f amily is the average of the ratio within a codon bias index in a family of a virus v, ENC v The same Z-score is evalueted for codon bias index CAI. Causes and Implications of Codon Usage Bias in RNA Viruses PLoS One The Coronavirus Surface Glycoprotein, the Coronaviridae Springer Genomic variance of the 2019-nCoV coronavirus Comparative genetic analysis of the novel coronavirus receptor ACE2 in different populations Analysis of the codon usage pattern in Middle East Respiratory Syndrome 319 Tool for the Selection of DNA and Protein Evolutionary Models Essentiality, conservation, evolutionary pressure and codon bias in 324 bacterial genomes Mutations in disordered proteins as early indicators of nucleic acid changes 326 triggering speciation Molecular Evolution of Human Coronavirus Genomes Nidovirales: Evolving the largest RNA virus 330 genome Codon catalog usage and the genome hypothesis Analysis of synonimous codon usage in SARS Coronavirus and other viruses in the 334 The extent of codon usage bias in human RNA viruses and its evolutionary 336 origin Cross-species transmission of the newly identified coronavirus 2019-nCoV Molecular Evolutionary Genetics Analysis across Computing Platforms Insights into the genetic and host 342 adaptability of emerging porcine circovirus A structural analysis of M protein in 345 coronavirus assembly and morphology The coronavirus E protein: assembly and beyond Viruses Analysis of preferred codon usage in the coronavirus N genes and their implications for genome 348 evolution and vaccine design Toroviruses, and Arteriviruses. Topley and Wilson's 350 Microbiology and Microbial Infections Clustal omega Directional mutation pressure and neutral molecular evolution Cloning, sequencing, expression, and purification 358 of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS